R&D, Pharmacovigilance & Regulatory Affairs

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

Title Sort ascending Location Date Req ID
Reset
Clinical Operations Intern
Clinical Operations Intern Toronto, CA Feb 12, 2026 6934
Toronto, CA Feb 12, 2026 6934
Clinical Program Leader
Clinical Program Leader Europe - Remote, IT Feb 2, 2026 5902
Europe - Remote, IT Feb 2, 2026 5902
Clinical Program Leader, Neonatology & Care
Clinical Program Leader, Neonatology & Care Europe, IT Feb 19, 2026 6955
Europe, IT Feb 19, 2026 6955
Clinical Trial Documentation & Records Management Lead Parma, IT Feb 15, 2026 6428
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT Jan 29, 2026 5993
PARMA, IT Jan 29, 2026 5993
Intern, Regulatory Affairs, Global Rare Diseases - Summer 2026 Cary, NC, US Feb 14, 2026 6413
Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT Feb 10, 2026 6592
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE Feb 6, 2026 351
R&D Manufacturing & Technology Transfer Manager Parma, IT Feb 18, 2026 6501
Senior Clinical Research Physician Non-Obstructive Respiratory Diseases UK, GB Feb 14, 2026 5448
Senior Director, Clinical Biometrics & Analytics Parma, IT Feb 12, 2026 6387
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT Feb 16, 2026 6111
Senior Global Project Manager
Senior Global Project Manager Cary, USA, US Feb 5, 2026 6561
Cary, USA, US Feb 5, 2026 6561
Senior Global Project Manager
Senior Global Project Manager Italy, IT Jan 30, 2026 6546
Italy, IT Jan 30, 2026 6546
Sr. Director, Clinical Programs, Global Rare Diseases Boston, MA, US Jan 24, 2026 6205
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US Jan 22, 2026 6204
United States, US Jan 22, 2026 6204